Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-11-18 16:29:10 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s0140-6736(26)01899-4
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0140673626018994
其他信息:
出版社: Elsevier BV
作者: Chong-Rui Xu; Yan Zhang; Guinan Lin; Haiyong Wang; Qiming Wang; Dingzhi Huang; Yan Yu; Jin Zhou; Hua Zhong; Lin Wu; Lingxiang Liu; Jianchun Duan; Zhiyi He; Yongzhong Luo; Hongxu Liu; Bi Chen; Xinmin Yu; Feng Xue; Qian Chu; Sanxing Guo; Runxiang Yang; Jia Zhong; Haifeng Liu; Longhua Sun; Xiaorong Dong; Haichuan Su; Peng Zhang; Bin Yang; Sisi He; Yuanyuan Ji; Lixin Wan; Xinghua Han; Jingyu Zhang; Fei Qiu; Lulu Yang; Wei Shi; Yi-Long Wu; Yi-Long Wu; Chong-Rui Xu; Min Shi; Guinan Lin; Yunjian Huang; Xiaojie Pan; Yongxing Chen; Feng Xue; Zhiyi He; Qiming Wang; Sanxing Guo; Jinbing Pan; Yuanyuan Ji; Lixin Wan; Yan Yu; Bin Yang; Xiaorong Dong; Tienan Yi; Yongzhong Luo; Lin Wu; Lingxiang Liu; Bi Chen; Xiaodong Jiang; Longhua Sun; Anwen Liu; Hongxu Liu; Yan Wang; Haiyong Wang; Jianhua Shi; Jing Wang; Chengpeng Gao; Jianchun Duan; Li Jia; Yu Yao; Haichuan Su; Jin Zhou; Yan Zhang; Dingzhi Huang; Chao Dong; Yu Zhang; Sisi He; Runxiang Yang; Dongqing Lv; Jian Lan; Mengxia Li; Qitao Yu; Shaozhang Zhou; Jian Fang; Jia Zhong; Haifeng Liu; Hua Zhong; Junbin Wang; Qian Chu; Di Wu; Zhigang Han; Ling Xu; Chengzhi Zhou; Jie Li; Yina Wang; Jun Wang; Pingli Wang; Xinmin Yu; Peng Zhang; Xinghua Han; Shenpeng Ying; Yong Li; Xiaotong Li
